BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 14612939)

  • 21. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
    Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
    Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.
    Liu Y; Pang JC; Dong S; Mao B; Poon WS; Ng HK
    Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer.
    Yu J; Leung WK; Ebert MP; Leong RW; Tse PC; Chan MW; Bai AH; To KF; Malfertheiner P; Sung JJ
    Br J Cancer; 2003 May; 88(10):1560-5. PubMed ID: 12771922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
    Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
    Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer.
    Sakuma M; Akahira J; Ito K; Niikura H; Moriya T; Okamura K; Sasano H; Yaegashi N
    Cancer Sci; 2007 Mar; 98(3):380-6. PubMed ID: 17270028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
    Ling Y; Shi X; Wang Y; Ling X; Li Q
    Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional silencing of the inhibin-α gene in human gastric carcinoma cells.
    Kim YI; Shim J; Kim BH; Lee SJ; Lee HK; Cho C; Cho BN
    Int J Oncol; 2012 Aug; 41(2):690-700. PubMed ID: 22581369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers.
    Virmani A; Rathi A; Heda S; Sugio K; Lewis C; Tonk V; Takahashi T; Roth JA; Minna JD; Euhus DM; Gazdar AF
    Int J Cancer; 2003 Nov; 107(3):341-5. PubMed ID: 14506731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma.
    Oue N; Shigeishi H; Kuniyasu H; Yokozaki H; Kuraoka K; Ito R; Yasui W
    Int J Cancer; 2001 Sep; 93(6):805-9. PubMed ID: 11519041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
    Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
    Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
    Chen B; He L; Savell VH; Jenkins JJ; Parham DM
    Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer.
    Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A
    Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic regulation of miR-196b expression in gastric cancer.
    Tsai KW; Hu LY; Wu CW; Li SC; Lai CH; Kao HW; Fang WL; Lin WC
    Genes Chromosomes Cancer; 2010 Nov; 49(11):969-80. PubMed ID: 20662076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.